Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
about
Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaDirectly observed therapy for treating tuberculosisRoutine surgery in addition to chemotherapy for treating spinal tuberculosis.Directly observed therapy for treating tuberculosisSurgery as an adjunct to chemotherapy for treating spinal tuberculosisPharmacokinetics of ethambutol under fasting conditions, with food, and with antacidsTetrameric structure of the GlfT2 galactofuranosyltransferase reveals a scaffold for the assembly of mycobacterial ArabinogalactanFew amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosisDuration of therapy for tuberculosis in patients infected with Human Immunodeficiency VirusPharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacidsIncidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosisThe antituberculosis drug ethionamide is activated by a flavoprotein monooxygenaseEthionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosisTreatment of tuberculosis in HaitiIsoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosisActivity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamideActivity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibilitySynergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophagesIn vitro antimycobacterial activity of 5-chloropyrazinamidePrevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of originExposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistorsExpression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferaseThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBTuberculosis and HIV: a partnership against the most vulnerable.Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected miceAssessment of tuberculosis treatment completion in an ethnically diverse population using two data sources. Implications for treatment interventions.Pharmacy data for tuberculosis surveillance and assessment of patient management.Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosisIdentification of new diamine scaffolds with activity against Mycobacterium tuberculosis.Treatment of isoniazid-resistant pulmonary tuberculosis.Personal and societal health quality lost to tuberculosis.Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysisComparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis.Don't forget tuberculosisIs switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?The safety of antituberculosis medications during breastfeeding.Tuberculosis contact investigation policies, practices, and challenges in 11 U.S. communities.Immigrant women's health: Infectious diseases--Part 1. Clinical assessment, tuberculosis, hepatitis, and malariaPerformance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran.Current medical treatment for tuberculosis.
P2860
Q22241907-199E5FCE-26CD-4525-99A0-DADF0D865F05Q24243188-41751123-44AF-460C-9DBF-154596FED52CQ24244849-CED1147B-F0C9-4DED-B985-4D59B8679C5BQ24246402-115FEB8F-A0BA-43EF-9437-D0438D55AFEDQ24247804-18D50B62-F0B2-4548-8804-0DC48EDB1D21Q24550662-F8217404-6240-49DD-B22A-90E0AEFDA177Q24608295-909645C6-75AA-4B8E-A90D-B61C30E32065Q24804809-A7591379-2A0A-4041-B78B-9208C7BCAC73Q26471837-FA91B855-001C-45AC-98E2-888D9F18C98FQ28200162-EB9C1706-6E9B-4A4B-AC66-C7064D975E86Q28207601-E6472D50-9BFF-4CEA-9E59-7F332A605650Q28217168-61FB4CA9-9325-4CE2-87E4-5A94610CCA77Q28344564-9A09FBD9-F5A0-4303-AE02-497C6B171A47Q28360407-62D8EC12-F237-4E69-A7BF-A4BC38B42C6FQ28362291-CBF5E282-2129-40A3-A506-3E11C3AC6B7AQ28367751-839BF591-9C23-41E8-95AE-35C5F411CD7FQ28379081-B5923DB4-5BCF-4CA6-88D9-2DEF62048A95Q28379126-93D0C211-B0F3-4378-B998-A21E6A523B59Q28379435-41D03351-BE84-40C6-92E0-38511E73B8DAQ28484926-71C43534-1B00-454E-B32E-B5F3BA79ADB1Q28487060-BF84B75E-C16C-4A95-8C73-7DEFBF831D55Q28493134-788F78A1-79B7-4B81-8EFE-621022A7AFDBQ28550707-2C032F51-8992-4FF6-BF44-071E2765E474Q30336184-ED245D93-49AB-4A06-A852-247084EFB368Q30421576-08C7832D-6A89-447A-B594-DEBD7E65AA52Q30776017-CC87ABB1-0962-4CC8-8743-E57E1CBB4F31Q30971319-D4469DC9-E198-4F4D-BB42-83510F499D93Q31991562-F6E76A72-E2B9-4C8B-9FA3-40B4501BB662Q33244525-18171021-06FD-4866-B1B4-A28640CE9590Q33315736-53758AC8-1F9C-48B7-82A9-940641A0B738Q33427787-1FF1010E-654A-4742-8A75-3816674FD6EDQ33532816-4652B638-E43D-49A9-9279-12896E5ED43EQ33562982-A7A61EAF-B14B-4DC9-8850-68227DD28662Q33567079-BF8279EB-F3FF-468A-90F6-87B740737417Q33577313-D0FA9E59-08BB-4BB7-ACBA-D8056B464B50Q33595131-65B5025C-84DB-4596-947B-1B0D8A3FF13FQ33726736-A2319757-F06C-4960-AB47-08DB01D13374Q33729297-B68B9EB2-D59F-4B2B-BE6B-E593134AE63AQ33739774-901B38E3-AE79-4CCD-BF13-79772D509C1DQ33813127-6FFDF5D6-88DF-4A3C-80D3-8E4B4A86D85F
P2860
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Treatment of tuberculosis and ...... isease Control and Prevention.
@ast
Treatment of tuberculosis and ...... isease Control and Prevention.
@en
Treatment of tuberculosis and ...... isease Control and Prevention.
@nl
type
label
Treatment of tuberculosis and ...... isease Control and Prevention.
@ast
Treatment of tuberculosis and ...... isease Control and Prevention.
@en
Treatment of tuberculosis and ...... isease Control and Prevention.
@nl
prefLabel
Treatment of tuberculosis and ...... isease Control and Prevention.
@ast
Treatment of tuberculosis and ...... isease Control and Prevention.
@en
Treatment of tuberculosis and ...... isease Control and Prevention.
@nl
P2093
P1476
Treatment of tuberculosis and ...... isease Control and Prevention.
@en
P2093
Bass JB Jr
Hopewell PC
Snider DE Jr
Thornton G
P304
P356
10.1164/AJRCCM.149.5.8173779
P407
P577
1994-05-01T00:00:00Z